Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Gross margin
Progyny, Inc.'s gross margin over the twelve months to 30 September 2026 was 24.9%, up 1.2 percentage points from fiscal 2025 (23.6%). Over the past ten years it has ranged from 15.2% (fiscal 2017) to 23.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Healthcare Plans industry median of 19.4% and below the Healthcare sector median of 54.5%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 23.6% | 1.92 |
| FY2024 | 21.7% | (0.23) |
| FY2023 | 21.9% | 0.68 |
| FY2022 | 21.3% | (1.14) |
| FY2021 | 22.4% | 2.08 |
| FY2020 | 20.3% | 0.51 |
| FY2019 | 19.8% | 1.37 |
| FY2018 | 18.4% | 3.21 |
| FY2017 | 15.2% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 24.5% | (0.94) |
| Jun 2026 | 25.5% | 0.19 |
| Mar 2026 | 25.3% | 1.14 |
| Dec 2025 | 24.2% | 0.91 |
| 28 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| CI Cigna Group compare | 88.4% |
| PGNY Progyny, Inc. | 24.9% |
| OSCR Oscar Health, Inc. compare | 20.6% |
| CLOV Clover Health Investments, Corp. compare | 18.9% |
| ELV Elevance Health, Inc. compare | 15.5% |
| HUM Humana Inc. compare | 13.0% |
| MOH Molina Healthcare, Inc compare | 12.6% |
| ALHC Alignment Healthcare, Inc. compare | 11.9% |
| CNC Centene Corporation compare | 7.78% |
| Healthcare Plans industry median | 19.4% |
| Healthcare sector median | 54.5% |
| Market median | 46.0% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement